BioForce Nanosciences Holdings, Inc.
BFNH
$0.45
-$0.0471-9.48%
OTC PK
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 8.36% | 0.98% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 8.36% | 0.98% | |||
| Operating Income | -8.36% | -0.98% | |||
| Income Before Tax | -658.69% | -0.98% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -658.69% | -0.98% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -658.69% | -0.98% | |||
| EBIT | -8.36% | -0.98% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -590.48% | 0.00% | |||
| Normalized Basic EPS | 0.00% | 0.00% | |||
| EPS Diluted | -590.48% | 0.00% | |||
| Normalized Diluted EPS | 0.00% | 0.00% | |||
| Average Basic Shares Outstanding | 10.16% | 0.00% | |||
| Average Diluted Shares Outstanding | 10.16% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||